

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 6.24522238 |
| 2 | membrane repolarization during action potential (GO:0086011) | 5.52705811 |
| 3 | sulfation (GO:0051923) | 4.54559177 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.52827926 |
| 5 | behavioral response to nicotine (GO:0035095) | 4.43505844 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.40862990 |
| 7 | magnesium ion transport (GO:0015693) | 4.20588741 |
| 8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.15602134 |
| 9 | plasma membrane repair (GO:0001778) | 4.09410054 |
| 10 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.07384744 |
| 11 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.06743334 |
| 12 | membrane repolarization (GO:0086009) | 3.98736087 |
| 13 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.92520957 |
| 14 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.89685647 |
| 15 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.87777763 |
| 16 | regulation of glomerulus development (GO:0090192) | 3.86719202 |
| 17 | positive regulation of synapse maturation (GO:0090129) | 3.84656332 |
| 18 | actin-myosin filament sliding (GO:0033275) | 3.83398878 |
| 19 | muscle filament sliding (GO:0030049) | 3.83398878 |
| 20 | positive regulation of fatty acid oxidation (GO:0046321) | 3.78416759 |
| 21 | regulation of germinal center formation (GO:0002634) | 3.75220221 |
| 22 | interferon-gamma secretion (GO:0072643) | 3.68354886 |
| 23 | regulation of cell communication by electrical coupling (GO:0010649) | 3.68329343 |
| 24 | membrane depolarization during action potential (GO:0086010) | 3.65261606 |
| 25 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.58493137 |
| 26 | cellular response to ATP (GO:0071318) | 3.58302223 |
| 27 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.58192689 |
| 28 | cardiac myofibril assembly (GO:0055003) | 3.57217508 |
| 29 | sarcomere organization (GO:0045214) | 3.53832318 |
| 30 | cell proliferation in forebrain (GO:0021846) | 3.52929499 |
| 31 | myofibril assembly (GO:0030239) | 3.52039949 |
| 32 | regulation of DNA endoreduplication (GO:0032875) | 3.51239955 |
| 33 | pharyngeal system development (GO:0060037) | 3.50336001 |
| 34 | regulation of skeletal muscle contraction (GO:0014819) | 3.50053912 |
| 35 | regulation of sequestering of triglyceride (GO:0010889) | 3.47455950 |
| 36 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.46398459 |
| 37 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.46019131 |
| 38 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.45107776 |
| 39 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.43422066 |
| 40 | regulation of synapse maturation (GO:0090128) | 3.39720114 |
| 41 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.38065625 |
| 42 | cellular response to exogenous dsRNA (GO:0071360) | 3.35639840 |
| 43 | cardiac muscle cell action potential (GO:0086001) | 3.35277274 |
| 44 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.33075463 |
| 45 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.32936262 |
| 46 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.31321507 |
| 47 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.27343557 |
| 48 | regulation of mesoderm development (GO:2000380) | 3.26929588 |
| 49 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.25664169 |
| 50 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.25131931 |
| 51 | actin-mediated cell contraction (GO:0070252) | 3.25112687 |
| 52 | response to inactivity (GO:0014854) | 3.22683032 |
| 53 | regulation of synapse structural plasticity (GO:0051823) | 3.18008679 |
| 54 | detection of calcium ion (GO:0005513) | 3.17285527 |
| 55 | cell communication by electrical coupling (GO:0010644) | 3.15179078 |
| 56 | vocalization behavior (GO:0071625) | 3.14088585 |
| 57 | presynaptic membrane organization (GO:0097090) | 3.11630244 |
| 58 | positive regulation of potassium ion transport (GO:0043268) | 3.10879594 |
| 59 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.08250124 |
| 60 | cardiac muscle contraction (GO:0060048) | 3.07896540 |
| 61 | response to electrical stimulus (GO:0051602) | 3.07517421 |
| 62 | cellular response to electrical stimulus (GO:0071257) | 3.06938883 |
| 63 | parturition (GO:0007567) | 3.05896468 |
| 64 | prostate gland growth (GO:0060736) | 3.05068146 |
| 65 | regulation of female receptivity (GO:0045924) | 3.02361988 |
| 66 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.99586355 |
| 67 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.99586355 |
| 68 | multicellular organismal signaling (GO:0035637) | 2.99294172 |
| 69 | regulation of actin filament-based movement (GO:1903115) | 2.95928068 |
| 70 | somite development (GO:0061053) | 2.95271124 |
| 71 | serotonin metabolic process (GO:0042428) | 2.94752785 |
| 72 | regulation of membrane repolarization (GO:0060306) | 2.92636295 |
| 73 | negative regulation of platelet activation (GO:0010544) | 2.88871802 |
| 74 | striated muscle contraction (GO:0006941) | 2.88455478 |
| 75 | layer formation in cerebral cortex (GO:0021819) | 2.87559351 |
| 76 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.86737360 |
| 77 | gamma-aminobutyric acid transport (GO:0015812) | 2.86097895 |
| 78 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.85312832 |
| 79 | cell communication involved in cardiac conduction (GO:0086065) | 2.85270062 |
| 80 | ovulation cycle (GO:0042698) | 2.85106889 |
| 81 | positive regulation of glomerulus development (GO:0090193) | 2.84157562 |
| 82 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.83645731 |
| 83 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.82837495 |
| 84 | negative regulation of appetite (GO:0032099) | 2.81501825 |
| 85 | negative regulation of response to food (GO:0032096) | 2.81501825 |
| 86 | locomotory exploration behavior (GO:0035641) | 2.81481116 |
| 87 | regulation of relaxation of muscle (GO:1901077) | 2.80493629 |
| 88 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.79513120 |
| 89 | skeletal muscle contraction (GO:0003009) | 2.79336873 |
| 90 | neuronal action potential propagation (GO:0019227) | 2.77604609 |
| 91 | relaxation of cardiac muscle (GO:0055119) | 2.76365058 |
| 92 | presynaptic membrane assembly (GO:0097105) | 2.76237239 |
| 93 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.76161020 |
| 94 | regulation of cardioblast proliferation (GO:0003264) | 2.76161020 |
| 95 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.75631876 |
| 96 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.72542306 |
| 97 | regulation of sarcomere organization (GO:0060297) | 2.72254095 |
| 98 | synaptic vesicle maturation (GO:0016188) | 2.72143788 |
| 99 | opsonization (GO:0008228) | 2.71681115 |
| 100 | regulation of tight junction assembly (GO:2000810) | 2.71287080 |
| 101 | cellular anion homeostasis (GO:0030002) | 2.70202079 |
| 102 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.70106805 |
| 103 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.69594309 |
| 104 | potassium ion homeostasis (GO:0055075) | 2.69463553 |
| 105 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.69359633 |
| 106 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.67761121 |
| 107 | action potential (GO:0001508) | 2.65832034 |
| 108 | activation of protein kinase A activity (GO:0034199) | 2.64367567 |
| 109 | synaptic vesicle exocytosis (GO:0016079) | 2.63670876 |
| 110 | flavonoid metabolic process (GO:0009812) | 2.63337690 |
| 111 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.63211203 |
| 112 | actin filament-based movement (GO:0030048) | 2.62999766 |
| 113 | otic vesicle formation (GO:0030916) | 2.62727430 |
| 114 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.62105778 |
| 115 | regulation of striated muscle contraction (GO:0006942) | 2.61951985 |
| 116 | glutamate secretion (GO:0014047) | 2.61699070 |
| 117 | skeletal muscle adaptation (GO:0043501) | 2.61059177 |
| 118 | dentate gyrus development (GO:0021542) | 2.60763569 |
| 119 | actomyosin structure organization (GO:0031032) | 2.60641841 |
| 120 | regulation of potassium ion transport (GO:0043266) | 2.60409958 |
| 121 | positive regulation of cation channel activity (GO:2001259) | 2.60234791 |
| 122 | primary amino compound metabolic process (GO:1901160) | 2.59845724 |
| 123 | interkinetic nuclear migration (GO:0022027) | 2.59647454 |
| 124 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.58309156 |
| 125 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.58309156 |
| 126 | potassium ion import (GO:0010107) | 2.53772700 |
| 127 | glutamate receptor signaling pathway (GO:0007215) | 2.53645519 |
| 128 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.53209764 |
| 129 | cellular potassium ion homeostasis (GO:0030007) | 2.52931749 |
| 130 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.52803308 |
| 131 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.51941855 |
| 132 | positive regulation of metanephros development (GO:0072216) | 2.49962825 |
| 133 | cardiac muscle hypertrophy (GO:0003300) | 2.46848244 |
| 134 | regulation of cation channel activity (GO:2001257) | 2.45536493 |
| 135 | neuron recognition (GO:0008038) | 2.44869927 |
| 136 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.44614509 |
| 137 | NADH dehydrogenase complex assembly (GO:0010257) | 2.44614509 |
| 138 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.44614509 |
| 139 | kynurenine metabolic process (GO:0070189) | 2.44597600 |
| 140 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.44180441 |
| 141 | lymphangiogenesis (GO:0001946) | 2.43311953 |
| 142 | muscle cell cellular homeostasis (GO:0046716) | 2.42543093 |
| 143 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.42007097 |
| 144 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.42007097 |
| 145 | protein localization to synapse (GO:0035418) | 2.41585188 |
| 146 | striated muscle hypertrophy (GO:0014897) | 2.39300357 |
| 147 | membrane assembly (GO:0071709) | 2.38093525 |
| 148 | female mating behavior (GO:0060180) | 2.37252547 |
| 149 | aorta morphogenesis (GO:0035909) | 2.36463939 |
| 150 | tooth mineralization (GO:0034505) | 2.36261164 |
| 151 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.35869365 |
| 152 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.34615624 |
| 153 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.33197938 |
| 154 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.32845097 |
| 155 | regulation of cardiac muscle contraction (GO:0055117) | 2.32051250 |
| 156 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.30373254 |
| 157 | exploration behavior (GO:0035640) | 2.30057693 |
| 158 | cardiac conduction (GO:0061337) | 2.29123515 |
| 159 | negative regulation of potassium ion transport (GO:0043267) | 2.27387148 |
| 160 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.27121136 |
| 161 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.27055661 |
| 162 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.26892612 |
| 163 | muscle contraction (GO:0006936) | 2.26824374 |
| 164 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.26613917 |
| 165 | muscle hypertrophy (GO:0014896) | 2.26128412 |
| 166 | negative regulation of protein localization to cell surface (GO:2000009) | 2.25772978 |
| 167 | axon extension (GO:0048675) | 2.25378836 |
| 168 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.25056806 |
| 169 | dendrite morphogenesis (GO:0048813) | 2.24934021 |
| 170 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.24832392 |
| 171 | adrenergic receptor signaling pathway (GO:0071875) | 2.24747009 |
| 172 | proline transport (GO:0015824) | 2.23625495 |
| 173 | dendritic spine morphogenesis (GO:0060997) | 2.23407372 |
| 174 | relaxation of muscle (GO:0090075) | 2.22943771 |
| 175 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.22551282 |
| 176 | striated muscle adaptation (GO:0014888) | 2.22292988 |
| 177 | axonal fasciculation (GO:0007413) | 2.21924788 |
| 178 | carnitine shuttle (GO:0006853) | 2.20905878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.97628913 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.67800554 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.58395274 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.29030848 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.79907480 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.61269629 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.46228133 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.33968564 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.33674156 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.33674156 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.32942662 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.27531630 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.23016556 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.13619590 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.13541969 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.99313149 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98877077 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.98862476 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.95757339 |
| 20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.94149221 |
| 21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.88659186 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77411032 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.74087018 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74066089 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.71098984 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.69671367 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.69263534 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60671717 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60431590 |
| 30 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.59442119 |
| 31 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.56203396 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.55816761 |
| 33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.49056194 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45052682 |
| 35 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44902111 |
| 36 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44379062 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.44319111 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42706871 |
| 39 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.42685041 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42453532 |
| 41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41203755 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35396236 |
| 43 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33391008 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.32806418 |
| 45 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.31519829 |
| 46 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.31519829 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.31241180 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29421087 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28964936 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28781075 |
| 51 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.28723483 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27951646 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.26950015 |
| 54 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.25545508 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25397314 |
| 56 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24901083 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24410021 |
| 58 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21454916 |
| 59 | EWS_26573619_Chip-Seq_HEK293_Human | 1.20796576 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20604507 |
| 61 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20581346 |
| 62 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20300390 |
| 63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17847545 |
| 64 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16977030 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16921519 |
| 66 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.16776281 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16771405 |
| 68 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16440792 |
| 69 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16168074 |
| 70 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.14738299 |
| 71 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13749718 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13429274 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.12941766 |
| 74 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.12758262 |
| 75 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12717711 |
| 76 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12266534 |
| 77 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12221324 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.07886881 |
| 79 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07776897 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07578680 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07271485 |
| 82 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07238884 |
| 83 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07017061 |
| 84 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06097643 |
| 85 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05974931 |
| 86 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.05429173 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05376611 |
| 88 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05138650 |
| 89 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04325425 |
| 90 | AR_19668381_ChIP-Seq_PC3_Human | 1.04029889 |
| 91 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03411509 |
| 92 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02890975 |
| 93 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02593786 |
| 94 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02474741 |
| 95 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02256751 |
| 96 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02256751 |
| 97 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.01584082 |
| 98 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00459090 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00306047 |
| 100 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99453351 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99244979 |
| 102 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99069860 |
| 103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98715715 |
| 104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97552166 |
| 105 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97546373 |
| 106 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97438421 |
| 107 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.97430708 |
| 108 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.96567522 |
| 109 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96128922 |
| 110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95595541 |
| 111 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95491264 |
| 112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94946077 |
| 113 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.93863226 |
| 114 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92170578 |
| 115 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91908321 |
| 116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90186301 |
| 117 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90118606 |
| 118 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89846125 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89846125 |
| 120 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89678166 |
| 121 | TCF4_23295773_ChIP-Seq_U87_Human | 0.89281767 |
| 122 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89035283 |
| 123 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88974007 |
| 124 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87798239 |
| 125 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87558618 |
| 126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87307635 |
| 127 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86873755 |
| 128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86844731 |
| 129 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86731671 |
| 130 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.86583913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.14029391 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.85713441 |
| 3 | MP0000751_myopathy | 3.76803036 |
| 4 | MP0003646_muscle_fatigue | 3.62771924 |
| 5 | MP0004145_abnormal_muscle_electrophysio | 3.24071698 |
| 6 | MP0004130_abnormal_muscle_cell | 2.87725166 |
| 7 | MP0004084_abnormal_cardiac_muscle | 2.78583877 |
| 8 | MP0005646_abnormal_pituitary_gland | 2.76075514 |
| 9 | MP0004036_abnormal_muscle_relaxation | 2.74333908 |
| 10 | MP0004215_abnormal_myocardial_fiber | 2.64254276 |
| 11 | MP0004885_abnormal_endolymph | 2.63516636 |
| 12 | MP0000749_muscle_degeneration | 2.60892737 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.37286360 |
| 14 | MP0003879_abnormal_hair_cell | 2.32625147 |
| 15 | MP0004270_analgesia | 2.30942387 |
| 16 | MP0001485_abnormal_pinna_reflex | 2.23940242 |
| 17 | MP0005620_abnormal_muscle_contractility | 2.20305782 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.19878112 |
| 19 | MP0004484_altered_response_of | 2.18630211 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.18440802 |
| 21 | MP0004087_abnormal_muscle_fiber | 2.12883377 |
| 22 | MP0005330_cardiomyopathy | 2.07357067 |
| 23 | MP0002106_abnormal_muscle_physiology | 2.06664238 |
| 24 | MP0002972_abnormal_cardiac_muscle | 2.03649621 |
| 25 | MP0004510_myositis | 1.97564032 |
| 26 | MP0003880_abnormal_central_pattern | 1.93720102 |
| 27 | MP0002160_abnormal_reproductive_system | 1.87991380 |
| 28 | MP0002063_abnormal_learning/memory/cond | 1.87558293 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.86217952 |
| 30 | MP0000747_muscle_weakness | 1.80376860 |
| 31 | MP0009745_abnormal_behavioral_response | 1.78665517 |
| 32 | MP0005369_muscle_phenotype | 1.76527981 |
| 33 | MP0000049_abnormal_middle_ear | 1.72314603 |
| 34 | MP0000750_abnormal_muscle_regeneration | 1.71220442 |
| 35 | MP0003303_peritoneal_inflammation | 1.69142354 |
| 36 | MP0009250_abnormal_appendicular_skeleto | 1.66361875 |
| 37 | MP0000759_abnormal_skeletal_muscle | 1.63394877 |
| 38 | MP0004134_abnormal_chest_morphology | 1.62012869 |
| 39 | MP0003137_abnormal_impulse_conducting | 1.60134149 |
| 40 | MP0002064_seizures | 1.58901167 |
| 41 | MP0005623_abnormal_meninges_morphology | 1.56819980 |
| 42 | MP0003724_increased_susceptibility_to | 1.54182852 |
| 43 | MP0005670_abnormal_white_adipose | 1.52883613 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.51636179 |
| 45 | MP0004085_abnormal_heartbeat | 1.51182153 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.50378516 |
| 47 | MP0005385_cardiovascular_system_phenoty | 1.49672795 |
| 48 | MP0001544_abnormal_cardiovascular_syste | 1.49672795 |
| 49 | MP0000631_abnormal_neuroendocrine_gland | 1.48584198 |
| 50 | MP0008775_abnormal_heart_ventricle | 1.48479583 |
| 51 | MP0006138_congestive_heart_failure | 1.46191872 |
| 52 | MP0004858_abnormal_nervous_system | 1.46011094 |
| 53 | MP0002638_abnormal_pupillary_reflex | 1.45953023 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.45106222 |
| 55 | MP0004142_abnormal_muscle_tone | 1.43608541 |
| 56 | MP0000013_abnormal_adipose_tissue | 1.42471470 |
| 57 | MP0008872_abnormal_physiological_respon | 1.41620541 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.40524603 |
| 59 | MP0009046_muscle_twitch | 1.38991961 |
| 60 | MP0000678_abnormal_parathyroid_gland | 1.38056667 |
| 61 | MP0005167_abnormal_blood-brain_barrier | 1.37933383 |
| 62 | MP0004233_abnormal_muscle_weight | 1.37931518 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.37597418 |
| 64 | MP0002572_abnormal_emotion/affect_behav | 1.37234938 |
| 65 | MP0001968_abnormal_touch/_nociception | 1.34984765 |
| 66 | MP0002269_muscular_atrophy | 1.32098669 |
| 67 | MP0009053_abnormal_anal_canal | 1.30840420 |
| 68 | MP0005389_reproductive_system_phenotype | 1.29901906 |
| 69 | MP0002734_abnormal_mechanical_nocicepti | 1.27166487 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 1.25065792 |
| 71 | MP0004272_abnormal_basement_membrane | 1.25011387 |
| 72 | MP0006072_abnormal_retinal_apoptosis | 1.23783878 |
| 73 | MP0010630_abnormal_cardiac_muscle | 1.23401115 |
| 74 | MP0002736_abnormal_nociception_after | 1.20775950 |
| 75 | MP0005171_absent_coat_pigmentation | 1.18651984 |
| 76 | MP0001879_abnormal_lymphatic_vessel | 1.18061019 |
| 77 | MP0003195_calcinosis | 1.17541339 |
| 78 | MP0006292_abnormal_olfactory_placode | 1.12807771 |
| 79 | MP0001486_abnormal_startle_reflex | 1.12408424 |
| 80 | MP0001542_abnormal_bone_strength | 1.10383640 |
| 81 | MP0002089_abnormal_postnatal_growth/wei | 1.10122902 |
| 82 | MP0003828_pulmonary_edema | 1.09579630 |
| 83 | MP0002272_abnormal_nervous_system | 1.08014219 |
| 84 | MP0002108_abnormal_muscle_morphology | 1.07316315 |
| 85 | MP0008438_abnormal_cutaneous_collagen | 1.06763343 |
| 86 | MP0008569_lethality_at_weaning | 1.03406303 |
| 87 | MP0002067_abnormal_sensory_capabilities | 1.03003141 |
| 88 | MP0005187_abnormal_penis_morphology | 1.00180431 |
| 89 | MP0005423_abnormal_somatic_nervous | 0.99310360 |
| 90 | MP0001502_abnormal_circadian_rhythm | 0.98727519 |
| 91 | MP0002234_abnormal_pharynx_morphology | 0.98690435 |
| 92 | MP0000026_abnormal_inner_ear | 0.97786773 |
| 93 | MP0005248_abnormal_Harderian_gland | 0.97766511 |
| 94 | MP0001765_abnormal_ion_homeostasis | 0.96936244 |
| 95 | MP0010368_abnormal_lymphatic_system | 0.96643646 |
| 96 | MP0003329_amyloid_beta_deposits | 0.96542232 |
| 97 | MP0004924_abnormal_behavior | 0.93972754 |
| 98 | MP0005386_behavior/neurological_phenoty | 0.93972754 |
| 99 | MP0000778_abnormal_nervous_system | 0.93844213 |
| 100 | MP0002733_abnormal_thermal_nociception | 0.93266584 |
| 101 | MP0005535_abnormal_body_temperature | 0.93233300 |
| 102 | MP0003638_abnormal_response/metabolism_ | 0.92802508 |
| 103 | MP0005595_abnormal_vascular_smooth | 0.92713323 |
| 104 | MP0000383_abnormal_hair_follicle | 0.92533768 |
| 105 | MP0002735_abnormal_chemical_nociception | 0.91621624 |
| 106 | MP0001958_emphysema | 0.91069375 |
| 107 | MP0002184_abnormal_innervation | 0.89654022 |
| 108 | MP0005551_abnormal_eye_electrophysiolog | 0.89600598 |
| 109 | MP0008877_abnormal_DNA_methylation | 0.89469712 |
| 110 | MP0001905_abnormal_dopamine_level | 0.89222203 |
| 111 | MP0001963_abnormal_hearing_physiology | 0.88449116 |
| 112 | MP0003942_abnormal_urinary_system | 0.85994053 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85926137 |
| 114 | MP0009384_cardiac_valve_regurgitation | 0.83675158 |
| 115 | MP0003075_altered_response_to | 0.83333777 |
| 116 | MP0003633_abnormal_nervous_system | 0.82740097 |
| 117 | MP0003938_abnormal_ear_development | 0.81723928 |
| 118 | MP0002127_abnormal_cardiovascular_syste | 0.81217085 |
| 119 | MP0001970_abnormal_pain_threshold | 0.80334257 |
| 120 | MP0002557_abnormal_social/conspecific_i | 0.80174705 |
| 121 | MP0002163_abnormal_gland_morphology | 0.79506268 |
| 122 | MP0010386_abnormal_urinary_bladder | 0.78594781 |
| 123 | MP0003937_abnormal_limbs/digits/tail_de | 0.77720008 |
| 124 | MP0000733_abnormal_muscle_development | 0.77483004 |
| 125 | MP0004133_heterotaxia | 0.77180048 |
| 126 | MP0004811_abnormal_neuron_physiology | 0.76730680 |
| 127 | MP0001299_abnormal_eye_distance/ | 0.75517242 |
| 128 | MP0002066_abnormal_motor_capabilities/c | 0.75065967 |
| 129 | MP0003045_fibrosis | 0.74776285 |
| 130 | MP0003690_abnormal_glial_cell | 0.74140656 |
| 131 | MP0000343_altered_response_to | 0.73981434 |
| 132 | MP0002971_abnormal_brown_adipose | 0.73794726 |
| 133 | MP0006276_abnormal_autonomic_nervous | 0.72684208 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.70267025 |
| 135 | MP0002896_abnormal_bone_mineralization | 0.69902456 |
| 136 | MP0003705_abnormal_hypodermis_morpholog | 0.68421651 |
| 137 | MP0002295_abnormal_pulmonary_circulatio | 0.68094998 |
| 138 | MP0005165_increased_susceptibility_to | 0.67924304 |
| 139 | MP0003091_abnormal_cell_migration | 0.66374164 |
| 140 | MP0002090_abnormal_vision | 0.66169385 |
| 141 | MP0005275_abnormal_skin_tensile | 0.65791994 |
| 142 | MP0003385_abnormal_body_wall | 0.64415190 |
| 143 | MP0002877_abnormal_melanocyte_morpholog | 0.64378296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.37130181 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 4.95307473 |
| 3 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.94508505 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 4.88889609 |
| 5 | Sudden death (HP:0001699) | 4.72839470 |
| 6 | Muscle fiber inclusion bodies (HP:0100299) | 4.37986078 |
| 7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.32534844 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 4.23446822 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 4.10171356 |
| 10 | Genetic anticipation (HP:0003743) | 4.01142623 |
| 11 | Muscle fiber splitting (HP:0003555) | 4.00142965 |
| 12 | Nemaline bodies (HP:0003798) | 3.92277661 |
| 13 | Focal motor seizures (HP:0011153) | 3.73295919 |
| 14 | Short 1st metacarpal (HP:0010034) | 3.70559316 |
| 15 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.70559316 |
| 16 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.66761898 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 3.64832119 |
| 18 | Difficulty running (HP:0009046) | 3.58470623 |
| 19 | Decreased circulating renin level (HP:0003351) | 3.53741017 |
| 20 | Conjunctival hamartoma (HP:0100780) | 3.51536026 |
| 21 | Short hallux (HP:0010109) | 3.46055810 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 3.44297100 |
| 23 | Morphological abnormality of the middle ear (HP:0008609) | 3.41985181 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 3.41048594 |
| 25 | Atrial fibrillation (HP:0005110) | 3.34814413 |
| 26 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.31014780 |
| 27 | Subaortic stenosis (HP:0001682) | 3.31014780 |
| 28 | Persistence of primary teeth (HP:0006335) | 3.28732791 |
| 29 | Difficulty climbing stairs (HP:0003551) | 3.24761891 |
| 30 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.22144371 |
| 31 | Primary atrial arrhythmia (HP:0001692) | 3.21817067 |
| 32 | Abnormality of the 1st metacarpal (HP:0010009) | 3.18221728 |
| 33 | Myoglobinuria (HP:0002913) | 3.16569804 |
| 34 | Abolished electroretinogram (ERG) (HP:0000550) | 3.16394232 |
| 35 | Short femoral neck (HP:0100864) | 3.11018173 |
| 36 | Ventricular tachycardia (HP:0004756) | 3.10994974 |
| 37 | Increased connective tissue (HP:0009025) | 3.09733824 |
| 38 | Myotonia (HP:0002486) | 3.08648879 |
| 39 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.05924770 |
| 40 | Abnormality of the renal collecting system (HP:0004742) | 3.05892747 |
| 41 | Periauricular skin pits (HP:0100277) | 2.98761094 |
| 42 | Preauricular pit (HP:0004467) | 2.98761094 |
| 43 | Supraventricular tachycardia (HP:0004755) | 2.98189174 |
| 44 | Bundle branch block (HP:0011710) | 2.96896097 |
| 45 | Supraventricular arrhythmia (HP:0005115) | 2.96563378 |
| 46 | Fibular aplasia (HP:0002990) | 2.96447434 |
| 47 | Hemiplegia (HP:0002301) | 2.96431153 |
| 48 | Stenosis of the external auditory canal (HP:0000402) | 2.92267877 |
| 49 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.90352515 |
| 50 | Paralysis (HP:0003470) | 2.85922723 |
| 51 | Absent phalangeal crease (HP:0006109) | 2.84988785 |
| 52 | Syncope (HP:0001279) | 2.82497624 |
| 53 | Short phalanx of the thumb (HP:0009660) | 2.81314352 |
| 54 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.76465196 |
| 55 | Visual hallucinations (HP:0002367) | 2.75318533 |
| 56 | Spinal rigidity (HP:0003306) | 2.74254984 |
| 57 | Agitation (HP:0000713) | 2.73905654 |
| 58 | Increased variability in muscle fiber diameter (HP:0003557) | 2.73433207 |
| 59 | Clumsiness (HP:0002312) | 2.72863777 |
| 60 | Hamartoma of the eye (HP:0010568) | 2.71980550 |
| 61 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.70958632 |
| 62 | Myopathic facies (HP:0002058) | 2.70325431 |
| 63 | Prolonged QT interval (HP:0001657) | 2.70133423 |
| 64 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.69317396 |
| 65 | Asymmetric septal hypertrophy (HP:0001670) | 2.68012875 |
| 66 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.65374782 |
| 67 | Short 4th metacarpal (HP:0010044) | 2.65374782 |
| 68 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.65286571 |
| 69 | Oligodontia (HP:0000677) | 2.64765854 |
| 70 | Focal seizures (HP:0007359) | 2.64135956 |
| 71 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.62000339 |
| 72 | Lipoatrophy (HP:0100578) | 2.56772658 |
| 73 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.52867820 |
| 74 | Abnormality of the nasal septum (HP:0000419) | 2.51592999 |
| 75 | Pendular nystagmus (HP:0012043) | 2.48073262 |
| 76 | Abnormality of binocular vision (HP:0011514) | 2.46726960 |
| 77 | Diplopia (HP:0000651) | 2.46726960 |
| 78 | Muscle stiffness (HP:0003552) | 2.44219094 |
| 79 | Congenital, generalized hypertrichosis (HP:0004540) | 2.44102338 |
| 80 | Fused cervical vertebrae (HP:0002949) | 2.44078497 |
| 81 | Frequent falls (HP:0002359) | 2.42095222 |
| 82 | Buphthalmos (HP:0000557) | 2.41233424 |
| 83 | Abnormal finger flexion creases (HP:0006143) | 2.40690249 |
| 84 | Distal arthrogryposis (HP:0005684) | 2.39134292 |
| 85 | Bone cyst (HP:0012062) | 2.38246251 |
| 86 | Right ventricular cardiomyopathy (HP:0011663) | 2.37752780 |
| 87 | Round ear (HP:0100830) | 2.34703513 |
| 88 | Congenital sensorineural hearing impairment (HP:0008527) | 2.31955656 |
| 89 | Generalized tonic-clonic seizures (HP:0002069) | 2.31691789 |
| 90 | Goiter (HP:0000853) | 2.30848769 |
| 91 | Synostosis of carpal bones (HP:0005048) | 2.30564629 |
| 92 | Adactyly (HP:0009776) | 2.30017748 |
| 93 | Skin pits (HP:0100276) | 2.29550782 |
| 94 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26342233 |
| 95 | Atonic seizures (HP:0010819) | 2.25131727 |
| 96 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.24883236 |
| 97 | Radial bowing (HP:0002986) | 2.24633761 |
| 98 | Furrowed tongue (HP:0000221) | 2.23946119 |
| 99 | Hyperkalemia (HP:0002153) | 2.22267651 |
| 100 | Meningioma (HP:0002858) | 2.21090948 |
| 101 | Abnormality of the frontal sinuses (HP:0002687) | 2.20731767 |
| 102 | Absence seizures (HP:0002121) | 2.19948213 |
| 103 | Ventricular arrhythmia (HP:0004308) | 2.19158610 |
| 104 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.16466717 |
| 105 | Lower limb amyotrophy (HP:0007210) | 2.16266953 |
| 106 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.16026920 |
| 107 | Neck muscle weakness (HP:0000467) | 2.15583760 |
| 108 | Abnormal EKG (HP:0003115) | 2.14731098 |
| 109 | Osteomalacia (HP:0002749) | 2.13869878 |
| 110 | Lip pit (HP:0100267) | 2.12474651 |
| 111 | Anomalous pulmonary venous return (HP:0010772) | 2.12163901 |
| 112 | Porencephaly (HP:0002132) | 2.11585484 |
| 113 | Pancreatic cysts (HP:0001737) | 2.10032385 |
| 114 | Small hand (HP:0200055) | 2.09483676 |
| 115 | Asplenia (HP:0001746) | 2.09345505 |
| 116 | Limb-girdle muscle weakness (HP:0003325) | 2.08015079 |
| 117 | Broad metatarsal (HP:0001783) | 2.07885336 |
| 118 | Muscular dystrophy (HP:0003560) | 2.06609129 |
| 119 | Keratoconus (HP:0000563) | 2.05901646 |
| 120 | Increased corneal curvature (HP:0100692) | 2.05901646 |
| 121 | Heart block (HP:0012722) | 2.05397280 |
| 122 | Ventricular fibrillation (HP:0001663) | 2.05091498 |
| 123 | Hypoplasia of the uterus (HP:0000013) | 2.04528697 |
| 124 | Congenital stationary night blindness (HP:0007642) | 2.04265917 |
| 125 | Nephronophthisis (HP:0000090) | 2.03971608 |
| 126 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.03885179 |
| 127 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.03675850 |
| 128 | Mesomelia (HP:0003027) | 2.03476164 |
| 129 | Slender build (HP:0001533) | 2.02549060 |
| 130 | Decreased central vision (HP:0007663) | 2.02141777 |
| 131 | Broad-based gait (HP:0002136) | 2.01781062 |
| 132 | Gaze-evoked nystagmus (HP:0000640) | 2.01532378 |
| 133 | Hypoplasia of the ulna (HP:0003022) | 1.99144144 |
| 134 | Pancreatic fibrosis (HP:0100732) | 1.98900398 |
| 135 | Scapular winging (HP:0003691) | 1.98784789 |
| 136 | Incomplete penetrance (HP:0003829) | 1.97968527 |
| 137 | Megalencephaly (HP:0001355) | 1.97963886 |
| 138 | Impaired smooth pursuit (HP:0007772) | 1.96893634 |
| 139 | Dialeptic seizures (HP:0011146) | 1.96112160 |
| 140 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.95746109 |
| 141 | Abnormal atrioventricular conduction (HP:0005150) | 1.95571423 |
| 142 | Dilated cardiomyopathy (HP:0001644) | 1.95385831 |
| 143 | Left ventricular hypertrophy (HP:0001712) | 1.91803476 |
| 144 | Rimmed vacuoles (HP:0003805) | 1.91005978 |
| 145 | Myokymia (HP:0002411) | 1.90836110 |
| 146 | Pheochromocytoma (HP:0002666) | 1.88757682 |
| 147 | Absent speech (HP:0001344) | 1.88103600 |
| 148 | Distal lower limb amyotrophy (HP:0008944) | 1.87638175 |
| 149 | Dysmetric saccades (HP:0000641) | 1.86503661 |
| 150 | Central scotoma (HP:0000603) | 1.83745859 |
| 151 | Gowers sign (HP:0003391) | 1.83389447 |
| 152 | Rapidly progressive (HP:0003678) | 1.83048843 |
| 153 | Action tremor (HP:0002345) | 1.81594247 |
| 154 | Epileptic encephalopathy (HP:0200134) | 1.78651222 |
| 155 | Febrile seizures (HP:0002373) | 1.78274481 |
| 156 | Poor eye contact (HP:0000817) | 1.77500007 |
| 157 | Palpitations (HP:0001962) | 1.77074213 |
| 158 | Anxiety (HP:0000739) | 1.76316213 |
| 159 | Rhabdomyolysis (HP:0003201) | 1.75016391 |
| 160 | Supranuclear gaze palsy (HP:0000605) | 1.73740046 |
| 161 | Retinal atrophy (HP:0001105) | 1.73480210 |
| 162 | Hypoplastic ischia (HP:0003175) | 1.72773181 |
| 163 | Shoulder girdle muscle weakness (HP:0003547) | 1.72651620 |
| 164 | Cerebral inclusion bodies (HP:0100314) | 1.70824976 |
| 165 | Ulnar deviation of the wrist (HP:0003049) | 1.70211549 |
| 166 | Limb-girdle muscle atrophy (HP:0003797) | 1.69769046 |
| 167 | Hyperventilation (HP:0002883) | 1.69757377 |
| 168 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.66997637 |
| 169 | Retinal dysplasia (HP:0007973) | 1.65969710 |
| 170 | Depression (HP:0000716) | 1.65080590 |
| 171 | Distal lower limb muscle weakness (HP:0009053) | 1.64460973 |
| 172 | Type II lissencephaly (HP:0007260) | 1.63983088 |
| 173 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.63973402 |
| 174 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.63973402 |
| 175 | Atrioventricular block (HP:0001678) | 1.63223364 |
| 176 | Neoplasm of the adrenal gland (HP:0100631) | 1.60480858 |
| 177 | Ankle clonus (HP:0011448) | 1.59400355 |
| 178 | Impaired social interactions (HP:0000735) | 1.59309044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.31435410 |
| 2 | PHKG2 | 3.15263833 |
| 3 | PHKG1 | 3.15263833 |
| 4 | GRK1 | 2.85014387 |
| 5 | ADRBK2 | 2.75778933 |
| 6 | BLK | 2.59056439 |
| 7 | TLK1 | 2.58049155 |
| 8 | OBSCN | 2.54437285 |
| 9 | MARK1 | 2.39929378 |
| 10 | EPHA4 | 2.34643912 |
| 11 | RIPK4 | 2.33999449 |
| 12 | DMPK | 2.25311851 |
| 13 | NTRK3 | 2.25069967 |
| 14 | MAP3K4 | 2.00420554 |
| 15 | TRIB3 | 1.80647253 |
| 16 | PRKD3 | 1.77401480 |
| 17 | TAOK3 | 1.72257089 |
| 18 | BMPR1B | 1.67259348 |
| 19 | MAP3K9 | 1.66334925 |
| 20 | NEK9 | 1.63721902 |
| 21 | MAP2K4 | 1.56613252 |
| 22 | KSR2 | 1.53968129 |
| 23 | SGK494 | 1.53884090 |
| 24 | SGK223 | 1.53884090 |
| 25 | MINK1 | 1.50272097 |
| 26 | DAPK2 | 1.45721779 |
| 27 | LMTK2 | 1.45139940 |
| 28 | TNIK | 1.41000332 |
| 29 | PLK2 | 1.40781818 |
| 30 | PTK2B | 1.40575511 |
| 31 | ACVR1B | 1.39988548 |
| 32 | PAK6 | 1.38606785 |
| 33 | MAP2K7 | 1.37580067 |
| 34 | TIE1 | 1.36244861 |
| 35 | RIPK1 | 1.35313622 |
| 36 | PAK3 | 1.30361069 |
| 37 | LATS2 | 1.24811619 |
| 38 | PIK3CA | 1.21289296 |
| 39 | PRKD2 | 1.20932536 |
| 40 | MUSK | 1.20550492 |
| 41 | PINK1 | 1.18607765 |
| 42 | FER | 1.17754035 |
| 43 | ARAF | 1.16748581 |
| 44 | MYLK | 1.16475211 |
| 45 | PNCK | 1.15104048 |
| 46 | ERBB3 | 1.12077496 |
| 47 | AKT3 | 1.11992465 |
| 48 | PDK4 | 1.11234001 |
| 49 | PDK3 | 1.11234001 |
| 50 | PKN2 | 1.07820593 |
| 51 | NTRK2 | 1.07264384 |
| 52 | RPS6KA6 | 1.04464065 |
| 53 | CAMK1G | 1.04458782 |
| 54 | PDGFRA | 1.02693394 |
| 55 | CAMKK1 | 1.01775599 |
| 56 | MAPKAPK3 | 1.01112046 |
| 57 | KSR1 | 0.99636096 |
| 58 | SIK2 | 0.99585801 |
| 59 | MAPK12 | 0.96142291 |
| 60 | CAMK2A | 0.93223689 |
| 61 | TXK | 0.92285062 |
| 62 | RET | 0.92135741 |
| 63 | TAF1 | 0.91041466 |
| 64 | STK24 | 0.90848481 |
| 65 | IKBKB | 0.89101295 |
| 66 | ZAK | 0.88396340 |
| 67 | FES | 0.88081640 |
| 68 | ADRBK1 | 0.87880889 |
| 69 | GRK7 | 0.87849726 |
| 70 | WNK4 | 0.87833578 |
| 71 | TGFBR2 | 0.84577519 |
| 72 | BMPR2 | 0.84258075 |
| 73 | CDK5 | 0.84042847 |
| 74 | PDK2 | 0.83549471 |
| 75 | MOS | 0.82208133 |
| 76 | GRK5 | 0.81827413 |
| 77 | PRKCE | 0.81496071 |
| 78 | CAMK2D | 0.81209070 |
| 79 | RPS6KL1 | 0.80506341 |
| 80 | RPS6KC1 | 0.80506341 |
| 81 | MAP3K7 | 0.79908913 |
| 82 | CAMKK2 | 0.79625847 |
| 83 | MAPKAPK5 | 0.78686972 |
| 84 | NTRK1 | 0.78308136 |
| 85 | DDR2 | 0.77877274 |
| 86 | TRPM7 | 0.77746206 |
| 87 | MAPK13 | 0.77629894 |
| 88 | STK38 | 0.76969849 |
| 89 | NME1 | 0.75946480 |
| 90 | SGK1 | 0.75525292 |
| 91 | PRKCH | 0.75156106 |
| 92 | PRKACA | 0.73767931 |
| 93 | PRKD1 | 0.70730999 |
| 94 | MAP3K12 | 0.70511519 |
| 95 | ROCK1 | 0.70286607 |
| 96 | BMX | 0.69889532 |
| 97 | MAP3K1 | 0.69105258 |
| 98 | EPHB1 | 0.68805533 |
| 99 | MAP3K2 | 0.66410463 |
| 100 | INSRR | 0.66220771 |
| 101 | STK39 | 0.65030886 |
| 102 | MAPK4 | 0.63980054 |
| 103 | HIPK2 | 0.63225983 |
| 104 | CASK | 0.63137062 |
| 105 | PRKCG | 0.62783528 |
| 106 | CAMK2G | 0.62612641 |
| 107 | SYK | 0.62507870 |
| 108 | EPHA3 | 0.62247110 |
| 109 | FRK | 0.61027050 |
| 110 | ERBB2 | 0.60707956 |
| 111 | FGR | 0.60177117 |
| 112 | PDPK1 | 0.60094435 |
| 113 | LATS1 | 0.58777185 |
| 114 | SGK3 | 0.58058982 |
| 115 | CAMK1 | 0.57003728 |
| 116 | PKN1 | 0.56586172 |
| 117 | FGFR3 | 0.56533086 |
| 118 | SGK2 | 0.55913196 |
| 119 | EPHB2 | 0.55876111 |
| 120 | MAPK7 | 0.55205637 |
| 121 | ILK | 0.54977434 |
| 122 | TEC | 0.54883095 |
| 123 | CDK9 | 0.54157987 |
| 124 | CSNK1G2 | 0.53405040 |
| 125 | PRKAA2 | 0.53170048 |
| 126 | STK11 | 0.52945559 |
| 127 | MAP2K1 | 0.52096763 |
| 128 | PRKACG | 0.52083574 |
| 129 | PIK3CG | 0.51898328 |
| 130 | PTK6 | 0.51787233 |
| 131 | CDC42BPA | 0.50869139 |
| 132 | PRKAA1 | 0.50782708 |
| 133 | MAP3K13 | 0.49088795 |
| 134 | CAMK2B | 0.48608855 |
| 135 | MAP3K5 | 0.48403888 |
| 136 | WNK1 | 0.47811843 |
| 137 | RPS6KA2 | 0.47446078 |
| 138 | RPS6KA5 | 0.47210483 |
| 139 | TYRO3 | 0.47204119 |
| 140 | STK3 | 0.46473014 |
| 141 | PDGFRB | 0.46165797 |
| 142 | RAF1 | 0.45805023 |
| 143 | MAP2K6 | 0.45588464 |
| 144 | CAMK4 | 0.44920787 |
| 145 | CHUK | 0.44370503 |
| 146 | CSK | 0.43083377 |
| 147 | RPS6KA3 | 0.41434243 |
| 148 | PRKG1 | 0.41338361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.68821658 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.27605029 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.05208998 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.04778347 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.02922234 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.02047741 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 1.89322638 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.77499274 |
| 9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.76174250 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.74258824 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.72108624 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.69895727 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.69034182 |
| 14 | Renin secretion_Homo sapiens_hsa04924 | 1.64889368 |
| 15 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63940855 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.63173775 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.62678912 |
| 18 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.61065879 |
| 19 | Morphine addiction_Homo sapiens_hsa05032 | 1.56239869 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.54997659 |
| 21 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.52713910 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.51873397 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.49296430 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.47673361 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.47283020 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46155729 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.41696432 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.41339593 |
| 29 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.40749104 |
| 30 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.37663503 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.36408811 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.33548272 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.28793488 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.28149755 |
| 35 | Melanoma_Homo sapiens_hsa05218 | 1.27298277 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.23834252 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19635905 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.19076398 |
| 39 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.11190595 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.11098216 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.10811261 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.10090300 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09861444 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 1.08136389 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04525228 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 1.04056267 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03564547 |
| 48 | Alcoholism_Homo sapiens_hsa05034 | 1.01332668 |
| 49 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00344421 |
| 50 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.96539223 |
| 51 | Asthma_Homo sapiens_hsa05310 | 0.96138981 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96096742 |
| 53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.93172076 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91196008 |
| 55 | Cocaine addiction_Homo sapiens_hsa05030 | 0.90867437 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.90477826 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.90215197 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89958577 |
| 59 | Glioma_Homo sapiens_hsa05214 | 0.89565729 |
| 60 | Axon guidance_Homo sapiens_hsa04360 | 0.86807307 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.85981722 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85465041 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85078226 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84021250 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.80605748 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.79995169 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79945583 |
| 68 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.79211630 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.78314861 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77801371 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.77037336 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76979868 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76626794 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76089005 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75704389 |
| 76 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73916550 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73803837 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73541108 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71792636 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71189565 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69657210 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.69154032 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68250066 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64543675 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64038951 |
| 86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63648417 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63616236 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62794507 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62780557 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58894286 |
| 91 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58791644 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58288694 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.57972301 |
| 94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57686949 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56725126 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.56498906 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56304299 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55834274 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55793438 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.55617698 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55606484 |
| 102 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55501054 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55321246 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55286009 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53999949 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53927260 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53819096 |
| 108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53524540 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52866059 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52370046 |
| 111 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.51101754 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.51076026 |
| 113 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50826793 |
| 114 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.50569505 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50295776 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49847563 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49835288 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49821697 |
| 119 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49727365 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49468438 |
| 121 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49464301 |
| 122 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49462932 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.49310274 |
| 124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47432760 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47232915 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46638874 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46393784 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46141622 |
| 129 | Phagosome_Homo sapiens_hsa04145 | 0.45736192 |
| 130 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45435358 |
| 131 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45227303 |
| 132 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45184047 |
| 133 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44248278 |
| 134 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38337580 |
| 135 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.38153637 |
| 136 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35963698 |
| 137 | ABC transporters_Homo sapiens_hsa02010 | 0.35844603 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35639402 |
| 139 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32597372 |
| 140 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.32202665 |

